Aegon Q4 2013 Analysts, Investors and Media Presentation

Alex Wynaendts Darryl Button
CEO CFO
The Hague – February 20, 2014
Q4 2013 Results

22
Key messages
 Solid fourth quarter completes strong 2013
 Continued strong sales driven by growth of deposit businesses
 Significant increase in market consistent value of new business
 Solid growth in underlying earnings
 Dividend supported by strong capital position and cash flows

3
Continued delivery of strong results
1,808
1,522
1,851 1,945
2010 2011 2012 2013
Underlying earnings before tax
(EUR million)
Operational free cash flows
(EUR billion)
Fee-based earnings
(% of UEBT)
Return on equity
(%)
8.6
6.7 7.4 7.4
2010 2011 2012 2013
1.3 1.2
1.6
1.3
2010 2011* 2012* 2013*
16%
30% 33% 33%
2010 2011 2012 2013
* Excluding market impacts

4
Additional market
transaction to hedge NL
longevity risk
Distribution strengthened
by addition of key
partnerships
Sale of Czech pension
fund & Positive Solutions
Partnership with Santander
started; Unnim, CAM ended
Execution of our strategy – 2013 milestones
Add-on acquisitions in
Romania and Ukraine
Creation of US shared
service center
Numerous external awards:
DC pension leader (US)
E-business leader (India)
Service innovation (China)
Best mortgage lender (NL)
Getting closer to customers
through expanded digital
capabilities
Introduction of simpler,
more customer-friendly
products
Implementation and roll-
out of Net Promoter Score
Employees across the
organization connected
through globally integrated
intranet
Strong growth for
UK platform
Conversion of preferred
shares, simplifying capital
structure
Customer License
Program helping
employees embrace
customer focus
Engage all employees in
strategy - 88% response
rate global employee
survey

5
 Gross deposits up 15% to EUR 10.6 billion driven by US variable annuities and pensions,
and strong third-party asset management flows; net deposits doubled to EUR 2 billion
 New life sales down following exceptionally strong UK and NL pension sales in Q4 2012
 Lower accident & health and general insurance mainly due to adverse currencies and lower
production in the Netherlands due to a focus on improving profitability
 Total sales* for 2013 increased 6%, or 9% at constant currencies
Continued strong sales driven by deposits
1.0 2.0
6.1 10.79.2 10.6
39.5
44.3
Q4 12 Q4 13 FY 2012 FY 2013
Gross deposits
(EUR billion)
212 199
823 807
Q4 12 Q4 13 FY 2012 FY 2013
A&H and general insurance
(EUR million)
 Net deposits excluding run-off
677 480
1,955 1,911
Q4 12 Q4 13 FY 2012 FY 2013
New life sales
(EUR million)
*Total sales consists of new life sales plus 1/10th of gross deposits plus new premiums for accident & health and general insurance

6
 Strong deposits in the Americas driven by growth in variable annuities and pensions
 Deposits in the Netherlands up 17% in Q4 on shift from insurance to bank savings products
 Strong increase in UK deposits driven by platform savings products
 Rise in New Markets on strong third-party asset management inflows, combined with
higher variable annuity production in Japan following the addition of new distributors
Q4 gross deposits higher in all units
United Kingdom
(GBP million)
Netherlands
(EUR million)
4Q12 4Q13 FY12 FY13
IS&R ES&P
Americas
(USD billion)
Gross deposits
282 329
4Q12 4Q13 FY12 FY13
1,338
12
52
4Q12 4Q13 FY12 FY13
New Markets
(EUR billion)
8.6 9.6
4Q12 4Q13 FY12 FY13
Other New Markets
Aegon Asset Management
2.3 3.2
34.7
37.7
1,484
30
239
10.9
14.3

7
Market consistent VNB
(EUR million)
Q4 12 Q4 13 FY 12 FY 13
 Americas
 The Netherlands
 United Kingdom
 New Markets
 Full year 2013 MCVNB increased 59% due to strong production
and management actions taken to improve profitability
 Strong MCVNB in the Americas compared with Q4 last year
► Variable annuities benefited from strong sales and margins
► Life up mainly on withdrawal and redesign of universal life products
 In the Netherlands value of new business decreased
► Pensions remained stable as higher margins offset lower production
► Lower contribution from mortgages as margins declined
 The UK was impacted by margin and volume pressure
 New markets benefited from strong improvement in Asia but
impacted by divestments in Spain and lower sales in Poland
Increase in value of new business on higher sales and margins
204
619
268
986

8
2008 2013
 Strong growth of fee business driven by US pensions and variable annuities as well as strong
net flows for Aegon Asset Management
 General account balance growth in NL and the UK more than offset decline in the Americas
► Institutional spread-based balances run-off from USD 33 billion in 2008 to USD 5 billion
► Fixed annuity balances decreased from USD 35 billion in 2008 to USD 16 billion
Growth in revenue generating investments reflect shift to fee business
Revenue generating investments
(EUR billion)
2008 2013 2008 2013 2008 2013
CAGR
+7%
3rd PARTY OFF-BALANCE SHEETFOR ACCOUNT OF POLICYHOLDERSGENERAL ACCOUNT
CAGR
9%
CAGR
1%
CAGR
13%
39%
28%
32%
35%
37%
29%
130 135
105
165
96
175
332
475

9
Disciplined focus on cost efficiency supports strategic investments
Cost reduction programs allow for increased investments without materially increasing total expenses
Cost reduction programs
 Extensive business transformation program in
the UK including recent closure of sales offices
 Consolidation of 13 divisions in the Americas
into 3, closure of several locations
 Creation of shared service center to realize
additional efficiencies in the Americas
 2011-2013 cost reduction program in NL
 Restructuring and deleveraging at the holding
Strategic investments
 Award-winning UK platform with upcoming
direct-to-consumer proposition
 Redesigned online NL intermediary capability
 New online channels to engage customers
► www.mijnAegon.nl
► www.TransamericaDirect.com
► www.Kroodle.nl
► www.Knab.nl
► www.buyonline.AegonReligare.com
► www.Aegon.es

10
Q4 12 Q1 13 Q2 13 Q3 13 Q4 13
461
 Earnings benefit from growth of variable annuities and pensions in the Americas more than offset by impact
weaker US dollar and one-time charges
 Higher earnings in the Netherlands mostly from a benefit from observed mortality
 UK earnings lower on investments in technology primarily related to new direct-to-consumer proposition
 Underlying earnings in New Markets lower as improvements in Asia were offset by the introduction of
insurance tax in Hungary and divestments
 Holding improvement due to lower expenses, deleveraging and a one-time gain related to interest on taxes
Underlying earnings up on favorable markets and lower leverage costs
(EUR million)
445 478 531 491
 United Kingdom
 New Markets
 Americas
 The Netherlands
 Holding
7%

11
Underlying
earnings before
tax Q4 13
Fair value items Realized gains
on investments
Impairment
charges
Other income Run-off
businesses
Income tax Net income
Q4 13
 Fair value items reflect the accounting mismatch on hedges following an increase in both equity
markets and interest rates as well as the impact of own credit spread movements
 Gains on investments resulting from portfolio changes in the Netherlands to align with new yield
curve used for regulatory solvency calculations
 Low impairments mainly reflect positive impact of RMBS recoveries in the US
 Other income impacted by charges related to business transformation program in the UK and
creation of a shared service center in the Americas
Net income impacted by fair value items
491 (260) 104 (1) (33) 14 (141) 174
Underlying earnings to net income development in Q4 2013
(EUR million)

12
Total fair value items of EUR (260) million
Fair value items impacted by accounting mismatch and credit spreads
Americas: 72
 Alternative investments
 Credit derivatives
 Real estate
Netherlands: (5)
 Alternative investments
 Real estate
US GMWB: (35)
 Guarantees net of hedges
Netherlands guarantees: (113)
 Guarantees net of hedges,
impacted by own credit spread
movement and model
refinements
US equity collar hedge: (75)
 Driven by higher equity
markets and volatility through
mid-December before expiration
US macro hedging: (58)
 GMIB delta hedge
 GMDB delta and rho hedge
 Other extreme event hedges
 New restructured macro hedge
Holding & other: 10
 Swaps related to hybrids
Holding: (38)
 Credit spread on MTN
 Foreign currency exchange
Other: (18)
 Longevity swap
 Foreign currency exchange
 Other
FV hedging with
accounting match*
EUR (148) million
Derivatives ∆: EUR (635)m
Liability ∆: EUR 487m
FV hedging without
accounting match
EUR (123) million
Derivatives ∆: EUR (123)m
Liability ∆: -
FV other
EUR (56) million
FV investments
EUR 67 million
* Except for changes in own credit spread and other non-hedged items

13
Adjusted equity hedge program reflecting lower equity market risk
 Equity macro and collar hedge programs combined into
single macro equity hedge program
 Protection of capital position continues to be main purpose
► Risk related to equity exposure came down due to rising equity
markets
► Hedge program restructured to current capital exposure
 IFRS accounting mismatch between hedges and liabilities
remains
 GMIB liability carried at amortized cost (SOP 03-1)
 Macro hedge carried at fair value
Macro hedge equity sensitivity
estimates for Q1 2014
Total equity return
in quarter
Fair value items
impact
+12% ~USD (120) million
+2% (base case) ~USD (60) million
-8% ~USD 0 million

14
2012 OFCF Dividends 2013 2012 OFCF Dividends 2013
165%
145%
700
0
 Group IGD ratio of 212%, reflecting strong operating unit regulatory capital positions
 US S&P excess capital of ~USD 500 million following Q4 dividend
 NL IGD ratio remains strong after paying an additional EUR 250 million dividend; market impacts
and one-time items supported stronger 2013 operational free cash flows
 UK Pillar 1 ratio strengthened by additional GBP 150 million capital contribution bringing it within
target range; operational free cash flows impacted by credit spreads and business transformation
costs
Solid capital positions – all business units at target capitalization levels
The Netherlands
(IGD ratio excl. Bank*)
United Kingdom
(Pillar 1 ratio incl. with-profit fund**)
United States
(USD million excess over S&P AA)
Target level Buffer level
250%
200%
(1,250)
950
500
800
130%
25%
(5%)
2012 OFCF Dividends 2013
205%
65%
(30%)
240% 150%
*2012 ratio excludes the benefit of the Ultimate Forward Rate
**2012 ratio includes GBP 200 million contingent capital agreement
Capital
contribution

15
 Operational free cash flows of EUR 228 million for the quarter
► Market impacts of EUR 36 million mostly related to the impact of lower credit spreads in the Netherlands
► One-time items of EUR (113) million including reserve strain related to term and UL business in the Americas,
valuation adjustments in the Netherlands and project costs in the UK
 Full year 2013 operational free cash flows of EUR 1.5 billion, equal to dividends to the holding
► EUR 220 million positive net impact of higher equity markets, higher interest rates and lower credit spreads
 Gross leverage ratio 30.1%; 2013 fixed charge coverage of 5.1x
Holding excess capital elevated prior to additional deleveraging
Operational free cash flows
(EUR million)
Q4 13 FY 13
Earnings on in-force 234 1,534
Return on free surplus 16 62
Release of required surplus 300 1,068
New business strain (322) (1,117)
Operational free cash flow 228 1,547
Market impacts & one-time items (76) 212
Normalized operational free cash flow 304 1,335
Q4 13 FY 13
Starting position 1.8 2.0
Net dividends received from business units 0.6 1.0
Acquisitions & divestments - 0.6
Common & preferred dividends - (0.4)
Cancellation of preferred shares - (0.4)
Funding & operating expenses (0.1) (0.4)
Other (0.1) (0.1)
Ending position 2.2 2.2
Capital allocated to 2014 deleveraging (0.9) (0.9)
Holding excess capital development
(EUR billion)

16
0
0.20*
0.21
0.22
2010 2011 2012 2013
 Proposed final 2013 dividend of EUR 0.11 per share, total 2013 dividend of EUR 0.22 per share
 Continue to neutralize stock dividends to avoid dilution
 Future dividend growth dependent on strong capital position and cash flows
Continued payment of sustainable dividends a strategic priority
0 0
140
340
460**
2010 2011 2012 2013 2014E
Dividends per share
(EUR per share)
* Final 2011 dividend of EUR 0.10 per share annualized
** Assumes 2014 interim dividend maintained at EUR 0.11 per share
Cash allocated to common dividends
(EUR million)
5% CAGR

1717
Key messages
 Solid fourth quarter completes strong 2013
 Continued strong sales driven by growth of deposit businesses
 Significant increase in market consistent value of new business
 Solid growth in underlying earnings
 Dividend supported by strong capital position and cash flows

18
Upcoming events Download
IR & Media App
in the appstore
March
Publication of 2013
Annual Report
March 21, 2014
Morgan Stanley
financials conference
London
March 27, 2014
Q1 2014 results
The Hague
May 15, 2014
May
Publication of adjusted
2013 financial statements
Mid-April, 2014
April
AIFA conference
Boca Raton, FL
March 3-4, 2014
Annual General Meeting
of Shareholders
The Hague
May 21, 2014

Appendix
For questions please contact Investor Relations
+31 70 344 8305
ir@aegon.com
P.O. Box 85
2501 CB The Hague
The Netherlands
Download
IR & Media App
in the appstore

20
 IFRS longevity reserves in the Netherlands based on prospective mortality tables as of Q1
2014
► IFRS capital in the Netherlands reduced by EUR 0.8-0.9 billion
► Positive impact on underlying earnings estimated at ~EUR 130 million* in 2014
 Valuation consistent with IGD solvency, Solvency II and internal economic framework
 Aegon assumes an improvement in life expectancy of approximately one to three months
each year by moving from observed to prospective mortality tables
► Increase is higher in the short term than in the long term
Longevity reserves based on prospective mortality tables
Life expectancy newborns Life expectancy 60 year olds
70
80
90
2012 2022 2032 2042 2052 2062
Male (old) Male (new) Female (old) Female (new)
70
80
90
2012 2022 2032 2042 2052 2062
Male (old) Male (new) Female (old) Female (new)
* Excluding the impact of observed mortality of EUR 25 million in Q4 2013

21
 Current capital allocated to run-off businesses of USD 2.2 billion
► Return on capital of run-off businesses of 1.8% in 2013
 Capital intensive run-off businesses negatively impact return on equity
► Capital allocated to run-off businesses is included in RoE calculations, but run-off earnings are not
Capital allocated to run-off businesses
Allocated capital to run-off businesses*
(USD billion)
Run-off period 2010 2011 2012 2013 2015E
 Payout annuities > 20 years 0.5 0.5 0.5 0.5 0.4
 Institutional spread-based business ~ 5 years 0.8 0.7 0.6 0.4 0.3
 BOLI/COLI > 10 years 0.7 0.5 0.5 0.5 0.5
 Life reinsurance ~ 15 years 3.1 1.4 1.2 0.7 0.7
5.1 3.1 2.8 2.2 1.9
* IFRS equity, excluding revaluation reserves

22
 Decreased new life sales in the Americas as universal life products were withdrawn or
redesigned to improve profitability
 New life sales decline in the Netherlands driven mostly by lower pension sales compared to
an exceptionally high Q4 2012
 Lower new life sales in the UK compared to increased activity just prior to RDR
 New Markets sales higher as growth in Asia offset a decline in CEE and stable sales in Spain
New life sales of EUR 480 million
191
154 154
Q4 12 Q3 13 Q4 13
New life sales
The Netherlands
(EUR million)
United Kingdom
(GBP million)
Americas
(USD million)
New Markets
(EUR million)
166
23
95
Q4 12 Q3 13 Q4 13
247
190 179
Q4 12 Q3 13 Q4 13
57 51
58
Q4 12 Q3 13 Q4 13

23
 US pension deposits up 15% driven by plan take-overs and successful efforts to increase
retirement awareness resulting in growing participation and contributions
 US variable annuity deposits increased 60% driven by favorable competitive environment
 Asset management inflows increased 37% mostly the result of strong institutional sales in
the Americas and the Netherlands
Strong deposits in pensions, variable annuities and asset management
Pensions Life Individual savings &
retirement
Asset management Gross deposits
4.7 0.4 2.7 2.9 10.6
Gross deposits Q4 2013
(EUR billions)

24
 Strong MCVNB growth in the Americas driven by higher variable annuity sales and margins,
and improvement in life insurance following product changes
 MCVNB in the Netherlands decreased mainly due to lower margins on new mortgage production
 Lower MCVNB in the UK driven by lower margins and volumes on annuities and lower volumes
in pensions
 New Markets MCVNB lower as strong results in Asia due to higher sales volumes more than
offset by divestments in Spain and lower sales in Poland
Market consistent value of new business of EUR 268 million
Market consistent value of new business
Americas
(USD million)
New Markets
(EUR million)
22
9
6
Q4 12 Q3 13 Q4 13
86
70
59
Q4 12 Q3 13 Q4 13
United Kingdom
(GBP million)
The Netherlands
(EUR million)
82
234 242
Q4 12 Q3 13 Q4 13
27 27
22
Q4 12 Q3 13 Q4 13

25
 Lower earnings in the Americas as the benefit of higher account balances was more than
offset by one-time charges
 Higher earnings in the Netherlands due mostly to a benefit from observed mortality
 UK earnings lower as higher life results more than offset by pensions mostly due to
additional investments in technology and adverse persistency
 New Markets earnings decreased as the impact of divestments in Spain and the insurance
tax in Hungary more than offset improvements in Asia
Underlying earnings increased to EUR 491 million
The Netherlands
(EUR million)
New Markets
(EUR million)
United Kingdom
(GBP million)
Americas
(USD million)
52
74
49
Q4 12 Q3 13 Q4 13
85 85
110
Q4 12 Q3 13 Q4 13
22 23
18
Q4 12 Q3 13 Q4 13
457
490
445
Q4 12 Q3 13 Q4 13

26
8.6
10.5 9.6
Q4 12 Q3 13 Q4 13
 Lower underlying earnings before tax as one-time charges more than offset the benefit of
higher balances in pensions, variable annuities and mutual funds
 Operating expenses increased 2% due mainly to higher investments to expand digital
presence and restructuring costs related to the creation of a shared services group
 New life sales decreased mostly due to the withdrawal and redesign of universal life
products with secondary guarantees to improve profitability
 Higher gross deposits driven by strong production in variable annuities and pensions
Americas
Underlying earnings
before tax (USD million)
New life sales
(USD million)
Gross deposits
(USD billion)
Operating expenses
(USD million)
489 506 500
Q4 12 Q3 13 Q4 13
457
490
445
Q4 12 Q3 13 Q4 13
191
154 154
Q4 12 Q3 13 Q4 13

27
 Higher underlying earnings mainly driven by a benefit from observed mortality
 Operating expenses down 2% as lower employee benefit expenses more than offset
investments in the business
 New life sales decreased due to lower pension sales compared to an exceptionally strong Q4
2012 and lower life sales reflecting the continuing shift from insurance to banking products
 Gross deposits increased as higher banking deposits more than offset lower inflows from
traditional savings products
The Netherlands
Underlying earnings
before tax (EUR million)
New life sales
(EUR million)
Gross deposits
(EUR million)
Operating expenses
(EUR million)
282 278
329
Q4 12 Q3 13 Q4 13
194 182 190
Q4 12 Q3 13 Q4 13
85 85
110
Q4 12 Q3 13 Q4 13
166
23
95
Q4 12 Q3 13 Q4 13

28
 Lower underlying earnings before tax as additional investments in technology and adverse
persistency in pensions more than offset higher life earnings due to reserving changes
 Operating expenses increased as costs related to investments in technology and business
transformation more than offset benefits of the cost reduction program
 Group pensions sales slowed compared to pre-RDR levels while platform sales continue to
remain strong, with balances reaching GBP 1.3 billion
 Increase in gross deposits as platform gains further momentum in the market
United Kingdom
Underlying earnings
before tax (GBP million)
New life sales
(GBP million)
Gross deposits
(GBP million)
Operating expenses
(GBP million)
12
86
52
Q4 12 Q3 13 Q4 13
68 78 84
Q4 12 Q3 13 Q4 13
22 23
18
Q4 12 Q3 13 Q4 13
247
190 179
Q4 12 Q3 13 Q4 13

29
 Lower underlying earnings before tax as improvements in Asia were more than offset by
the impact of divestments in Spain and the insurance tax in Hungary
 Operating expenses higher driven by higher variable expenses in asset management,
investments in Asia to support growth and the insurance tax in Hungary
 Higher new life sales driven mostly by the launch of a new universal life product in Asia and
strong sales from the joint venture with Santander in Spain
 Gross deposits increased 36% due mostly to higher institutional asset management
deposits in the US and the Netherlands
New Markets
Underlying earnings
before tax (EUR million)
New life sales
(EUR million)
Gross deposits
(EUR billion)
Operating expenses
(EUR million)
2.3
2.7
3.2
Q4 12 Q3 13 Q4 13
153 162
176
Q4 12 Q3 13 Q4 13
52
74
49
Q4 12 Q3 13 Q4 13
57 51
58
Q4 12 Q3 13 Q4 13

30
Sustainability efforts support strategy
Products and services customers can trust A responsible approach to investments Supporting local communities
A recognized strong foundation – Doing the “basics” well
 Introducing products that are
clearer and easier to understand
 Changing the product design
process so that each step
considers the value to the
customer
 Supporting market conduct
principles that focus on meeting
customers’ needs
 Decisions guided by
Responsible Investment Policy
 Clear standards in areas such
as child labor, the environment
and corruption
 Using influence to promote
sustainability governance and
economic development
 Long tradition of working
with and investing in local
communities
 Volunteering program
encourages employees to
take paid time-off to work
on local initiatives
 Supporting local charities
and good causes
worldwide

31
 Aegon ordinary shares
► Traded in Amsterdam (NYSE Euronext) since 1969
and quoted in Euros
 Aegon New York Registry Shares (NYRS)
► Traded on NYSE since 1991 and quoted in US
dollars
► Attractive option for US investors
► One (1) Aegon NYRS represents one (1) Aegon
Amsterdam-listed ordinary share
► Cost effective way to hold international securities
Investing in Aegon
Aegon’s ordinary shares
Aegon’s New York Registry Shares
Ticker symbol AGN NA
Underlying ISIN NL0000303709
SEDOL 5927375NL
Trading Platform Euronext Amsterdam
Country Netherlands
Aegon NYRS contact details
Broker contacts at Citibank N.A.:
Telephone: New York: +1 212 723 5435
London: +44 (0) 207 500 2030
E-mail: citiadr@citi.com
Ticker symbol AEG US
NYRS ISIN US0079241032
NYRS SEDOL 2008411US
Trading Platform NYSE
Country USA
NYRS Transfer Agent Citibank, N.A.

32
General account investments roll-forward
General account investment roll-forward
EUR billion Americas The Netherlands United Kingdom New Markets & Other
Opening balance September 30, 2013 78.5 44.4 10.8 3.6
Net in- and outflow (1.2) 1.0 0.0 (0.1)
Unrealized / realized results 0.0 (0.1) (0.1) (0.0)
Foreign exchange (1.5) 0.0 0.0 (0.0)
Closing balance December 31, 2013 75.8 45.3 10.7 3.5
 Americas includes balance reductions from the run-off of the institutional spread business of
EUR 0.1 billion and from fixed annuities of EUR 0.3 billion as the product is de-emphasized

33
 Actual income tax can deviate from the nominal tax rate, amongst others due to:
► Tax exempt income
► Tax credits
► Valuation allowances for tax losses
► Tax rate changes
Reconciliation of effective tax rate Q4 2013
► Cross border intercompany reinsurance
► Policyholder tax UK (offsetting)
► Other items
Reconciliation of effective tax rate Q4 2013
EUR million Americas The Netherlands United Kingdom New Markets/ Holdings Total
Income before tax 269 28 26 (8) 315
Nominal tax rate 35.0% (91) 25.0% (10) 23.25% (6) N/A 5 (102)
Actual income tax (111) (4) (23) (2) (141)
Net income 159 23 2 (10) 174

34
 10-year US Treasury assumed to grade up over ten years to 4.25%
 Credit spreads are assumed to grade down over two years to 110 bps
 Bond funds are assumed to return 4% for 10 years and 6% thereafter
 Money market rates are assumed to remain flat at 0.1% for two years followed by a 3-year
grading to 3%
 Annual gross equity market returns of 8% (price appreciation + dividends)
Main economic assumptions
Main US economic assumptions
Assumptions NL UK
10-year interest rate 2.5% 2.9%
3-month interest rate 0.3% 0.4%
Annual gross equity market return
(price appreciation + dividends)
7% 7%
EUR/USD rate of 1.35
EUR/GBP rate of 0.84

35
Cautionary note regarding non-IFRS measures
This document includes the non-IFRS financial measures: underlying earnings before tax, income tax, income before tax and market consistent value of new business. These non-IFRS measures are calculated by consolidating on a proportionate basis Aegon’s joint ventures and associated companies. The
reconciliation of these measures, except for market consistent value of new business, to the most comparable IFRS measure is provided in note 3 ‘Segment information’ of Aegon’s Condensed Consolidated Interim Financial Statements. Market consistent value of new business is not based on IFRS, which
are used to report Aegon’s primary financial statements and should not be viewed as a substitute for IFRS financial measures. Aegon may define and calculate market consistent value of new business differently than other companies. Aegon believes that its non-IFRS measures, together with the IFRS
information, provide meaningful information about the underlying operating results of Aegon’s business including insight into the financial measures that senior management uses in managing the business.
Local currencies and constant currency exchange rates
This document contains certain information about Aegon’s results, financial condition and revenue generating investments presented in USD for the Americas and GBP for the United Kingdom, because those businesses operate and are managed primarily in those currencies. Certain comparative
information presented on a constant currency basis eliminates the effects of changes in currency exchange rates. None of this information is a substitute for or superior to financial information about Aegon presented in EUR, which is the currency of Aegon’s primary financial statements.
Forward-looking statements
The statements contained in this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target, intend, may, expect, anticipate,
predict, project, counting on, plan, continue, want, forecast, goal, should, would, is confident, will, and similar expressions as they relate to Aegon. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Aegon undertakes no
obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking
statements due to changes caused by various risks and uncertainties. Such risks and uncertainties include but are not limited to the following:
 Changes in general economic conditions, particularly in the United States, the Netherlands and the United Kingdom;
 Changes in the performance of financial markets, including emerging markets, such as with regard to:
► The frequency and severity of defaults by issuers in Aegon’s fixed income investment portfolios;
► The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities Aegon holds; and
► The effects of declining creditworthiness of certain private sector securities and the resulting decline in the value of sovereign exposure that Aegon holds;
 Changes in the performance of Aegon’s investment portfolio and decline in ratings of Aegon’s counterparties;
 Consequences of a potential (partial) break-up of the euro;
 The frequency and severity of insured loss events;
 Changes affecting longevity, mortality, morbidity, persistence and other factors that may impact the profitability of Aegon’s insurance products;
 Reinsurers to whom Aegon has ceded significant underwriting risks may fail to meet their obligations;
 Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels;
 Changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates;
 Changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty creditworthiness;
 Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets;
 Changes in laws and regulations, particularly those affecting Aegon’s operations, ability to hire and retain key personnel, the products Aegon sells, and the attractiveness of certain products to its consumers;
 Regulatory changes relating to the insurance industry in the jurisdictions in which Aegon operates;
 Changes in customer behavior and public opinion in general related to, among other things, the type of products also Aegon sells, including legal, regulatory or commercial necessity to meet changing customer expectations;
 Acts of God, acts of terrorism, acts of war and pandemics;
 Changes in the policies of central banks and/or governments;
 Lowering of one or more of Aegon’s debt ratings issued by recognized rating organizations and the adverse impact such action may have on Aegon’s ability to raise capital and on its liquidity and financial condition;
 Lowering of one or more of insurer financial strength ratings of Aegon’s insurance subsidiaries and the adverse impact such action may have on the premium writings, policy retention, profitability and liquidity of its insurance subsidiaries;
 The effect of the European Union’s Solvency II requirements and other regulations in other jurisdictions affecting the capital Aegon is required to maintain;
 Litigation or regulatory action that could require Aegon to pay significant damages or change the way Aegon does business;
 As Aegon’s operations support complex transactions and are highly dependent on the proper functioning of information technology, a computer system failure or security breach may disrupt Aegon’s business, damage its reputation and adversely affect its results of operations, financial condition and
cash flows;
 Customer responsiveness to both new products and distribution channels;
 Competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for Aegon’s products;
 Changes in accounting regulations and policies or a change by Aegon in applying such regulations and policies, voluntarily or otherwise, may affect Aegon’s reported results and shareholders’ equity;
 The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items, including Aegon’s ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions;
 Catastrophic events, either manmade or by nature, could result in material losses and significantly interrupt Aegon’s business; and
 Aegon’s failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost saving initiatives.
Further details of potential risks and uncertainties affecting Aegon are described in its filings with the Netherlands Authority for the Financial Markets and the US Securities and Exchange Commission, including the Annual Report. These forward-looking statements speak only as of the date of this document.
Except as required by any applicable law or regulation, Aegon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Aegon’s expectations with regard thereto or any change in events,
conditions or circumstances on which any such statement is based.
Disclaimer

Aegon Q4 2013 Analysts, Investors and Media Presentation

More Related Content

What's hot (20)

Viewers also liked (12)

Similar to Aegon Q4 2013 Analysts, Investors and Media Presentation (17)

More from Aegon (20)

Recently uploaded (20)

Aegon Q4 2013 Analysts, Investors and Media Presentation